Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Statement re Offers for Subscription

3 Feb 2015 15:07

RNS Number : 9428D
Maven Income and Growth VCT 2 PLC
03 February 2015
 

Joint Announcement

 

Offers for Subscription - Maven VCT 2 Offer Fully Subscribed

 

Maven Income and Growth VCT plc ("Maven VCT 1"), Maven Income and Growth VCT 2 plc ("Maven VCT 2"), Maven Income and Growth VCT 3 plc ("Maven VCT 3"), Maven Income and Growth VCT 4 plc ("Maven VCT 4") and Maven Income and Growth VCT 5 plc ("Maven VCT 5") (together "the Companies" and each a "Company") are managed by Maven Capital Partners UK LLP ("Maven").

 

The Boards of the Companies launched offers for subscription to raise, in aggregate, up to £18 million ("the Offers" and each an "Offer"). Full details of the Offers are contained in a prospectus ("the Prospectus"), which was published by the Companies on 20 October 2014.

 

Further to the announcements of 7, 20 and 30 January 2015 that the respective Offers by Maven VCT 4, Maven VCT 1 and Maven VCT 3 were closed for further applications, the Companies are pleased to announce that applications have now been received for the full amount available under the Maven VCT 2 Offer and, as such, the Maven VCT 2 Offer is now also closed for further applications. Prospective investors can still apply to invest in Maven VCT 5 and the amount subscribed will be invested in new ordinary shares of 10p each in that Company.

 

The MIG 5 Offer will close at 12.00 noon on 28 April 2015 (unless fully subscribed by an earlier date or otherwise extended or closed at the Directors' discretion). Persons intending to apply under the MIG 5 Offer for the 2014/2015 tax year should note that the deadline for such applications is 12.00 noon on 1 April 2015.

 

The Prospectus was submitted to the Financial Conduct Authority and copies of the Prospectus are available for download from the Companies' websites:

 

· www.mavencp.com/migvct

· www.mavencp.com/migvct2

· www.mavencp.com/migvct3

· www.mavencp.com/migvct4

· www.mavencp.com/migvct5

 

and from the National Storage Mechanism (http://www.hemscott.com/nsm.do). For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

3 February 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STREXLFBELFBBBE
Date   Source Headline
19th Nov 201811:40 amRNSDirector/PDMR Shareholding
15th Nov 20183:36 pmRNSDirectorate Change
15th Nov 20183:01 pmRNSMerger Update: Approval of Scheme
8th Nov 20184:27 pmRNSNet Asset Value(s)
1st Nov 201812:31 pmRNSResult of General Meeting
8th Oct 20187:00 amRNSStatement re Proposed Merger
14th Sep 20183:37 pmRNSHalf-year Report
13th Sep 20186:16 pmRNSPossible Merger
31st Aug 20184:04 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:47 pmRNSStatement re DIS
18th May 20184:47 pmRNSNet Asset Value(s)
17th May 20184:30 pmRNSDividend Declaration
15th May 20181:49 pmRNSResult of AGM
24th Apr 20184:52 pmRNSIssue of Equity
13th Apr 201812:48 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
6th Apr 20184:41 pmRNSStatement re Dividend Investment Scheme
6th Apr 20184:34 pmRNSAnnual Financial Report
6th Apr 20189:23 amRNSDirector/PDMR Shareholding
6th Apr 20189:22 amRNSDirector/PDMR Shareholding
5th Apr 20186:23 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
8th Mar 20183:30 pmRNSDividend Declaration
6th Mar 20185:24 pmRNSTransaction in Own Shares
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
26th Feb 20184:25 pmRNSNet Asset Value(s)
6th Feb 20185:19 pmRNSDirector/PDMR Shareholding
6th Feb 20185:18 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:46 pmRNSPublication of Suppl.Prospcts
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
30th Nov 20174:27 pmRNSIssue of Equity
22nd Nov 20173:01 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:09 pmRNSStatement re NAV and Dividend Investment Scheme
9th Nov 20173:58 pmRNSNet Asset Value(s)
8th Nov 201710:10 amRNSResult of General Meeting
25th Oct 20173:00 pmRNSDividend Declaration
18th Oct 201710:43 amRNSReplacement Statement re Listing Application
17th Oct 20172:49 pmRNSStatement re Listing Application
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:48 pmRNSIssue of Equity
15th Sep 201710:08 amRNSStatement re NAV and Dividend Investment Scheme
8th Sep 20177:00 amRNSHalf-year Report
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
29th Aug 20174:11 pmRNSNet Asset Value(s)
10th Aug 20174:38 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.